A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis

NCT04693195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pruritus
Atopic Dermatitis

Interventions

DRUG: BLU-5937
DRUG: Placebo

Sponsor

Bellus Health Inc. - a GSK company